Synopsis: Bajaj Consumer Care delivered a strong FY26 performance with Rs 1,153 crore revenue and Rs 224 crore EBITDA, driven by margin expansion, pricing actions, and improved product mix. Distribution gains and brand-led growth supported profitability, while cost pressures were managed effectively, positioning the company for sustained margin strength and future growth.
Bajaj Consumer Care delivered a strong performance in FY26, marked by steady revenue growth and improved profitability. The company crossed Rs 1,000 crore in revenue and reported EBITDA of Rs 224 crore, reflecting a healthier financial position compared to previous periods. A solid fourth quarter further supported this momentum, with growth seen across key segments and markets. Despite operating in a challenging environment, the company maintained its performance trajectory, indicating a more stable and consistent growth outlook going forward.
A Breakout Year
Bajaj Consumer Care’s performance in FY26 can be seen as a clear example of the company turning around its fortunes, owing to top-line growth and margin improvement. Bajaj Consumer Care clocked Rs 1,153 crore net revenue, growing by 21%, and breaking the Rs 1,000 crore barrier for the very first time.
Reaching such milestones is a pointer towards the change in trajectory of the company’s performances. In addition to revenue growth, there have been improvements in profitability metrics; for instance, full-year EBITDA for Bajaj Consumer Care amounted to Rs 224 crores with an EBITDA margin of 19.5%, whereas PAT was recorded at Rs 190 crores at a margin of 16.5%.
Commenting on the results of FY26, the management said that this year was one of turning around; what we see today is not just a change in the trajectory of company performance but also a move away from lower profitability to better margins.
Strong Q4 Performance
An even clearer picture emerges when analysing performance for the fourth quarter separately. The standalone Q4 revenues amounted to Rs 308 crore, exhibiting an impressive growth of 28% YoY, whereas consolidated Q4 revenues were at Rs 327 crore, growing at 32%.
Quarterly performance in terms of profitability showed a sharp rise; the standalone EBITDA grew by 131% to Rs 78 crore, with the corresponding EBITDA margin at 25%. In consolidated terms, the EBITDA for Q4 was at Rs 77 crore, with the corresponding margin of 23.7%.
Similarly, PAT performance was also quite positive, with the standalone PAT figure at Rs 64.1 crore, showing a margin of 20.8%, and the consolidated PAT figure was at Rs 63.6 crore, with the corresponding margin of 19.5%.
Margins Lead Growth
Another important aspect contributing to the EBITDA growth has been the dramatic improvement in the gross margins. In Q4, the gross margin stood at 63%, while for the whole year, the gross margin increased to 60%, marking a margin improvement of around 650 basis points, compared to last year.
Factors such as pricing, revenue management, and pack optimisation played a vital role in improving the margin base of the company. Management further noted that the increase in gross margin is structural in nature and not cycle-related, implying that the margin will stay at the current level in the medium term. The improved margin base has contributed positively to the EBITDA growth of the company.
Pricing Lifts Realisations
One of the major strategies used for margin expansion is the company’s emphasis on price management. During the quarter, there have been MLH changes made by Bajaj Consumer Care. These steps have improved realisations for the company without affecting volume adversely.
Such pricing policies were backed up by higher transaction volumes, enabling the company to sustain its revenue trend while improving margins. However, the company also stated that some of the front-end pricing actions will need to be taken in future quarters due to the rising inflation trends. It can thus be seen that the company was able to maintain a good balance between volume and margin improvements through careful price management.
Mix Drives Profitability
One more crucial driver behind the growth in EBITDA has been the betterment in product mix. As mentioned by the company, the favorable shift in mix between Q3 and Q4 was one of the reasons behind improving margins.
The star product of the company, ADHO (Almond Drops Hair Oil), witnessed strong performance. It has grown its revenues by around 20% throughout the year, while volumes grew nearly double digits on an adjusted ml basis. This growth was achieved evenly across pack sizes and distribution channels.
Moreover, the company also saw revenues worth Rs 225 crore from its non-ADHO product portfolio, which itself has been earning profits for the company and will scale up in the coming periods.
Distribution Gains Momentum
Execution on the ground level has been instrumental in driving not only growth but also margins. Project Aarohan, a company’s distribution strategy, has yielded 2-3% incremental growth for some markets, while at the same time helping improve execution. The GT (general trade) channel saw recovery this year and achieved a high-teen percentage for the full year, whereas the organised trade witnessed growth in the 20s during Q4.
The organised trade accounts for about 30% of total revenues and has helped accelerate innovation and premiumisation. Urban markets have done well versus rural markets, with both GT and organised trade channels doing well.
Navigating Cost Pressures
Although margins were quite impressive, the firm had to contend with high input costs. The management noted that nearly all costs are experiencing inflationary pressure, including raw materials like mustard oil, copra, and packing materials, which are experiencing volatility.
Another factor contributing to the volatility in the LLP and packaging costs was the Gulf War. Nevertheless, the company addressed these cost pressures by using its inventory and being careful in its purchasing decisions, pricing, and cost controls. Furthermore, the company stated that it had enough inventory to cope with volatility in the short term.
Sustaining Margin Strength
For the future, the company intends to ensure that the EBITDA margin stays between low 20% and mid 20%, based on their conviction regarding sustaining improvements in their profitability. Although management did recognise that there were fluctuations in input prices, they were confident of their capability to adjust their strategy accordingly for the sake of ensuring margins.
Moreover, the firm has also planned to invest in the branding of their products, advertising, and digitalisation. The advertisement expenses have increased by 34% in Q4, compared to last year. Lastly, the non-ADHO portfolio will be expanded to reach up to Rs 500 crores within the next three years.
Conclusion
Bajaj Consumer Care’s Rs 224 crore EBITDA achievement in FY26 is not a one-off outcome but the result of a well-executed multi-pronged strategy. The company has successfully combined pricing discipline, mix improvement, distribution expansion, and cost management to drive margin expansion.
The improvement in gross margins, supported by strategic pricing and product mix changes, has been the primary driver of EBITDA growth. At the same time, strong execution across channels and brands has ensured that revenue growth remains robust.
While input cost volatility remains a challenge, the company’s proactive approach and operational discipline provide confidence in sustaining margins. With a stronger base, diversified portfolio, and continued focus on execution, Bajaj Consumer Care appears well-positioned to maintain its profitability trajectory in the coming years.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
